Press Releases
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses...
Clinical Trials
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Pivotal Phase Global Study
Pfizer Inc. and BioNTech SEÂ announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate a single...
News
AstraZeneca’s Calquence Receives Positive CHMP Opinion For Chronic Blood Cancer
AstraZeneca’s Calquence has been recommended for marketing authorisation in the EU for the treatment of adult patients with chronic lymphocytic leukaemia (CLL), the most...
Drug Research
Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline
Editas Medicine, Inc., a leading genome editing company, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
News
US to invest $472 million more in Moderna to speed up vaccine process
Moderna has unveiled a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) for an additional commitment of up to...
News
LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma
LGM Pharma announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The combination brings together...
News
Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon
Samsung Biologics (207940.KS) announced a plan to expand its Drug Product (DP) capability in line with increasing market demand and to ensure flexible production...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
